Sign In
Pharma
Biocon Q2FY22 revenue up by 10% at Rs 1,945 crore
Markets
Sebi confirms ban on 19 entities
Sebi bars Biocon's official in insider trading case
Economy
Covid 2nd wave hit India like a tsunami: Shaw
Abundant supply of Remdesivir by the second week of May: Kiran Mazumdar Shaw
Biocon's arm gets GMP compliance certificate from MHRA
Industry
Biocon Biologics appoints Umesh as CCO
